ENTITY

Caliway Biopharmaceuticals (6919 TT)

48
Analysis
Health Care • Taiwan
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
more
Company Event • 09 Nov 2026 12:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 12 Feb 2027 13:30 • Upcoming
Add To Calendar

Q4 2026

Company Event • 29 Sep 2026 10:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 31 Aug 2026 10:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 11 Aug 2026 13:30 • Upcoming
Add To Calendar

Q2 2026

x